A. They block negative T-cell signals B. They facilitate Natural Killer (NK) cells to recognize tumor cells as non-self C. They increase antigen expression on tumor cells D. They bind and stimulate T-cell growth factor receptors E. Unsure

A. There is no difference in the toxic mechanism, incidence, or management B. There is a difference in the toxic mechanism but not the incidence or management C. There is a difference in the toxic mechanism, incidence, and management D. There is a difference in incidence and management but not the toxic mechanism E. Unsure

A. Ongoing/prolonged communication, monitoring, and symptom queries are essential B. Intense pretreatment education about toxicity coupled with toxicity prophylaxis is key C. Less counseling and monitoring are required as ICIs are less toxic than cytotoxic chemotherapy D. Lab monitoring for potential adverse effects is critical throughout the duration of ICI therapy E. Unsure